Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Chlorothiazide is a thiazide diuretic (commonly called a "water pill") used to treat hypertension (high blood pressure) and edema (fluid retention) associated with conditions such as congestive heart failure, liver cirrhosis, kidney disease, or fluid retention caused by corticosteroid or estrogen therapy. It works primarily by inhibiting sodium and chloride reabsorption in the distal convoluted tubule of the nephron in the kidneys, leading to increased excretion of sodium, chloride, water, potassium, magnesium, phosphate, and bicarbonate. This diuretic effect reduces blood volume and helps lower blood pressure. Chlorothiazide may also cause arteriolar dilation. Additional uses include management of diabetes insipidus and prevention of kidney stones in patients with hypercalcemia[1][3][4][9].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on chlorothiazide.